Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Current pharmaceutical design

Showing results (71-80 of 10,652) with videos related to

Pageof 1,066
Sort By:
Current Pharmaceutical Design|March 23, 2011
Cardiovascular disease and dyslipidemia: beyond LDLJanine Pöss, Florian Custodis, Christian Werner, et al.
Current Pharmaceutical Design|March 23, 2011
The role of vitamin D in dyslipidemia and cardiovascular diseaseArmin Zittermann, Jan F Gummert, Jochen Börgermann
Current Pharmaceutical Design|April 8, 2011
The need to redefine antimicrobial drug discoveryEleftherios Mylonakis
Current Pharmaceutical Design|April 8, 2011
Microbial efflux pump inhibition: tactics and strategiesGeorge P Tegos, Mark Haynes, J Jacob Strouse, et al.
Current Pharmaceutical Design|April 8, 2011
Humanized SCID mice models of SLENikola Kerekov, Nikolina Mihaylova, Jozsef Prechl, et al.
Current Pharmaceutical Design|April 8, 2011
Anti-infective therapeutics from the Lepidopteran model host Galleria mellonellaAndreas Vilcinskas
Current Pharmaceutical Design|April 12, 2011
Pharmacological treatment of ADHD and the short and long term effects on sleepYu-Shu Huang, Ming-Horng Tsai, Christian Guilleminault
Current Pharmaceutical Design|April 12, 2011
Pharmacological treatment of obstructive sleep apneaVivien C Abad, Christian Guilleminault
Current Pharmaceutical Design|April 12, 2011
Lipoprotein(a): medical treatment options for an elusive moleculeKlaus G Parhofer
Current Pharmaceutical Design|March 8, 2011
The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's diseaseRui D S Prediger, Aderbal S Aguiar, Eduardo L G Moreira, et al.
Pageof 1,066

Showing results (71-80 of 10,652) with videos related to

Sort By:
Pageof 1,066
Current Pharmaceutical Design|March 23, 2011
Cardiovascular disease and dyslipidemia: beyond LDLJanine Pöss, Florian Custodis, Christian Werner, et al.
Current Pharmaceutical Design|March 23, 2011
The role of vitamin D in dyslipidemia and cardiovascular diseaseArmin Zittermann, Jan F Gummert, Jochen Börgermann
Current Pharmaceutical Design|April 8, 2011
The need to redefine antimicrobial drug discoveryEleftherios Mylonakis
Current Pharmaceutical Design|April 8, 2011
Microbial efflux pump inhibition: tactics and strategiesGeorge P Tegos, Mark Haynes, J Jacob Strouse, et al.
Current Pharmaceutical Design|April 8, 2011
Humanized SCID mice models of SLENikola Kerekov, Nikolina Mihaylova, Jozsef Prechl, et al.
Current Pharmaceutical Design|April 8, 2011
Anti-infective therapeutics from the Lepidopteran model host Galleria mellonellaAndreas Vilcinskas
Current Pharmaceutical Design|April 12, 2011
Pharmacological treatment of ADHD and the short and long term effects on sleepYu-Shu Huang, Ming-Horng Tsai, Christian Guilleminault
Current Pharmaceutical Design|April 12, 2011
Pharmacological treatment of obstructive sleep apneaVivien C Abad, Christian Guilleminault
Current Pharmaceutical Design|April 12, 2011
Lipoprotein(a): medical treatment options for an elusive moleculeKlaus G Parhofer
Current Pharmaceutical Design|March 8, 2011
The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's diseaseRui D S Prediger, Aderbal S Aguiar, Eduardo L G Moreira, et al.
Pageof 1,066